Quantcast

Latest Immunoglobulin E Stories

2011-05-06 06:30:00

SOUTH SAN FRANCISCO, Calif., May 6, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the company will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several Phase 1 clinical trials. Pfizer Inc.

2011-03-30 08:35:00

IRVINGTON, N.Y., March 30, 2011 /PRNewswire/ -- Itchy, runny nose, sneezing, watery eyes and itchy throat - we all know the symptoms that can make our children miserable from allergies.

2011-03-28 08:18:48

A drug that targets the antibody immunoglobulin E (IgE), a key player in asthma, nearly eliminated seasonal increases in asthma attacks and decreased asthma symptoms among young people living in inner city environments, a clinical trial sponsored by the National Institutes of Health has found.

2011-03-22 12:37:50

Some 3 million children in the United States have some form of food allergy, ranging in severity from mild to life-threatening.

2011-03-17 12:38:55

Stephen J. Teach, MD, MPH, Medical Director and Principal Investigator of IMPACT DC, a program of pediatric asthma care and research at Children's National Medical Center, served as the Site Principal Investigator for a new study that may advance asthma treatment and outcomes, specifically for inner-city children and teens.

2011-03-17 12:30:40

Researchers from Boston University School of Medicine (BUSM), in collaboration with researchers from the Inner City Asthma Consortium, have found that among inner-city children, the drug omalizumab improved asthma control, nearly eliminated seasonal exacerbations and reduced the need for controller medication.

2011-03-17 12:25:01

A drug that targets the antibody immunoglobulin E (IgE), a key player in asthma, nearly eliminated seasonal increases in asthma attacks and decreased asthma symptoms among young people living in inner city environments, a clinical trial sponsored by the National Institutes of Health has found.

2011-03-11 00:00:27

Cobalis Corp.'s PreHistin® Allergy Defense Formula, the first ever pre-histamine, has taken the coveted 2011 Best New Product Award at the ECRM Cough, Cold and Allergy show held in Orlando, FL, February 28-March 3.

2011-03-10 14:54:00

IRVINE, Calif., March 10, 2011 /PRNewswire/ -- Cobalis Corp.'s (Pink Sheets: CLSC) http://www.prehistin.com/ [PreHistin® Allergy Defense Formula], the first ever pre-histamine, has taken the coveted 2011 Best New Product Award at the ECRM Cough, Cold and Allergy show held in Orlando, FL, February 28-March 3.

8ef67e6bf1af387a756b86e0b43353f31
2011-03-10 14:15:47

A breakthrough by scientists at The University of Nottingham could provide hope for any allergy sufferers who have ever had to choose between their health and their household pet.


Word of the Day
whirret
  • To give a box on the ear to.
The word 'whirret' may be onomatopoeic.